BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16498165)

  • 1. Best evidence topic report. Intranasal naloxone in suspected opioid overdose.
    Ashton H; Hassan Z
    Emerg Med J; 2006 Mar; 23(3):221-3. PubMed ID: 16498165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 3: Is nebulised naloxone effective in opioid overdose?
    Ishiyama D; Jones J
    Emerg Med J; 2013 Oct; 30(10):860. PubMed ID: 24014692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised trial of intranasal versus intramuscular naloxone in prehospital treatment for suspected opioid overdose.
    Glaser A; Arakaki D; Chan GM; Hoffman RS
    Med J Aust; 2005 Apr; 182(8):427; author reply 427, 429. PubMed ID: 15850442
    [No Abstract]   [Full Text] [Related]  

  • 4. Intranasal naloxone administration for treatment of opioid overdose.
    Robinson A; Wermeling DP
    Am J Health Syst Pharm; 2014 Dec; 71(24):2129-35. PubMed ID: 25465584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Intravenous or intramuscular/subcutaneous naloxone in opioid overdose.
    Clarke S; Dargan P
    Emerg Med J; 2002 May; 19(3):249. PubMed ID: 11971843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Intravenous bolus or infusion of naloxone in opioid overdose.
    Clarke S; Dargan P
    Emerg Med J; 2002 May; 19(3):249-50. PubMed ID: 11971842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal naloxone administration by police first responders is associated with decreased opioid overdose deaths.
    Rando J; Broering D; Olson JE; Marco C; Evans SB
    Am J Emerg Med; 2015 Sep; 33(9):1201-4. PubMed ID: 26095132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary. Diagnosis of drug overdose by rapid reversal with naloxone.
    Barrie J; May G
    Emerg Med J; 2006 Nov; 23(11):874-5. PubMed ID: 17057146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose.
    Doe-Simkins M; Walley AY; Epstein A; Moyer P
    Am J Public Health; 2009 May; 99(5):788-91. PubMed ID: 19363214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised trial of intranasal versus intramuscular naloxone in prehospital treatment for suspected opioid overdose.
    Kelly AM; Kerr D; Dietze P; Patrick I; Walker T; Koutsogiannis Z
    Med J Aust; 2005 Jan; 182(1):24-7. PubMed ID: 15651944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of intranasal naloxone as a needleless alternative for treatment of opioid overdose in the prehospital setting.
    Barton ED; Colwell CB; Wolfe T; Fosnocht D; Gravitz C; Bryan T; Dunn W; Benson J; Bailey J
    J Emerg Med; 2005 Oct; 29(3):265-71. PubMed ID: 16183444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of Naloxone Redosing in the Age of the New Opioid Epidemic.
    Klebacher R; Harris MI; Ariyaprakai N; Tagore A; Robbins V; Dudley LS; Bauter R; Koneru S; Hill RD; Wasserman E; Shanes A; Merlin MA
    Prehosp Emerg Care; 2017; 21(6):682-687. PubMed ID: 28686547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two cases of intranasal naloxone self-administration in opioid overdose.
    Green TC; Ray M; Bowman SE; McKenzie M; Rich JD
    Subst Abus; 2014; 35(2):129-32. PubMed ID: 24821348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do heroin overdose patients require observation after receiving naloxone?
    Willman MW; Liss DB; Schwarz ES; Mullins ME
    Clin Toxicol (Phila); 2017 Feb; 55(2):81-87. PubMed ID: 27849133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence-Based Guidelines for EMS Administration of Naloxone.
    Williams K; Lang ES; Panchal AR; Gasper JJ; Taillac P; Gouda J; Lyng JW; Goodloe JM; Hedges M
    Prehosp Emerg Care; 2019; 23(6):749-763. PubMed ID: 30924736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic Properties and Human Use Characteristics of an FDA-Approved Intranasal Naloxone Product for the Treatment of Opioid Overdose.
    Krieter P; Chiang N; Gyaw S; Skolnick P; Crystal R; Keegan F; Aker J; Beck M; Harris J
    J Clin Pharmacol; 2016 Oct; 56(10):1243-53. PubMed ID: 27145977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal administration of naloxone by paramedics.
    Barton ED; Ramos J; Colwell C; Benson J; Baily J; Dunn W
    Prehosp Emerg Care; 2002; 6(1):54-8. PubMed ID: 11789651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal Naloxone for Opioid Overdose.
    Taylor JL; Lasser KE
    JAMA; 2024 Jan; 331(3):250-251. PubMed ID: 38127361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal Naloxone Administration.
    Ortega R; Nozari A; Baker W; Surani S; Edwards M
    N Engl J Med; 2021 Mar; 384(12):e44. PubMed ID: 33761209
    [No Abstract]   [Full Text] [Related]  

  • 20. An increase in per-patient naloxone requirements in an opioid epidemic.
    Birmingham LE; Nielson JA
    Am J Emerg Med; 2017 Dec; 35(12):1958-1959. PubMed ID: 28633907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.